Literature DB >> 8138718

Quantification of cholesterol in all lipoprotein classes by the VAP-II method.

K R Kulkarni1, D W Garber, S M Marcovina, J P Segrest.   

Abstract

We have developed a high resolution microvolume Vertical Auto Profile (VAP) method for the simultaneous measurement of cholesterol in all lipoprotein classes, including lipoprotein[a] (Lp[a]) and intermediate density lipoprotein (IDL). This method, designated as VAP-II, uses a non-segmented continuous flow (controlled-dispersion flow) analyzer for the enzymatic analysis of cholesterol in lipoprotein classes separated by a short spin (47 min) single vertical ultracentrifugation. Cholesterol concentrations of high (HDL), low (LDL), very low (VLDL), and intermediate (IDL) density lipoproteins, as well as Lp[a], are determined by decomposing the spectrophotometric absorbance curve, obtained from the continuous analysis of the centrifuged sample, into its components using software developed in this laboratory. Analysis by VAP-II is rapid and sensitive (as little as 40 microliters plasma is required per assay). The resolution of lipoprotein peaks is considerably enhanced in the present analyzer compared to the previous analyzer (VAP-I, which used the Technicon AutoAnalyzer); improvement is especially noticeable for Lp[a] and IDL. Total and lipoprotein cholesterol values obtained by VAP-II correlated well with the values obtained by Northwest Lipid Research Laboratories (NWLRL). VAP-II Lp[a] cholesterol values also correlated well with the Lp[a] mass values obtained by an immunoassay technique performed at NWLRL (r = 0.907). The reproducibility and accuracy of the method are within the requirements of the CDC-NHLBI (Centers for Disease Control-National Heart, Lung, and Blood Institute) Lipid Standardization Program.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138718

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

Review 1.  Specialized lipid profiles.

Authors:  Karen E Friday
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Lipid parameters for measuring risk of cardiovascular disease.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt; John J P Kastelein
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

Review 3.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

4.  HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the Lipoprotein Investigators Collaborative.

Authors:  Seth S Martin; Arif A Khokhar; Heidi T May; Krishnaji R Kulkarni; Michael J Blaha; Parag H Joshi; Peter P Toth; Joseph B Muhlestein; Jeffrey L Anderson; Stacey Knight; Yan Li; John A Spertus; Steven R Jones
Journal:  Eur Heart J       Date:  2014-06-30       Impact factor: 29.983

5.  Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention.

Authors:  Elena Flowers; Bradley E Aouizerat; Fahim Abbasi; Cynthia Lamendola; Kaylene M Grove; Yoshimi Fukuoka; Gerald M Reaven
Journal:  Metabolism       Date:  2015-05-28       Impact factor: 8.694

6.  The utility of the apolipoprotein A1 remnant ratio in predicting incidence coronary heart disease in a primary prevention cohort: The Jackson Heart Study.

Authors:  Heidi T May; John R Nelson; Seth T Lirette; Krishnaji R Kulkarni; Jeffrey L Anderson; Michael E Griswold; Benjamin D Horne; Adolfo Correa; Joseph B Muhlestein
Journal:  Eur J Prev Cardiol       Date:  2015-10-19       Impact factor: 7.804

7.  Association of lipoprotein subfractions and coronary artery calcium in patient at intermediate cardiovascular risk.

Authors:  Borut Jug; Jenny Papazian; Robert Lee; Matthew J Budoff
Journal:  Am J Cardiol       Date:  2012-11-07       Impact factor: 2.778

8.  Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets.

Authors:  Marie-Pierre St-Onge; Sijian Zhang; Betty Darnell; David B Allison
Journal:  J Nutr       Date:  2009-04       Impact factor: 4.798

9.  Overestimation of HDL-cholesterol using a homogeneous "direct" assay.

Authors:  Wei Zhao; Carolyn Chaffin; Renee A Desmond; Bruce Hodges; Thomas M Daly; C Andrew Robinson; Robert W Hardy
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

10.  Corn oil intake favorably impacts lipoprotein cholesterol, apolipoprotein and lipoprotein particle levels compared with extra-virgin olive oil.

Authors:  K C Maki; A L Lawless; K M Kelley; V N Kaden; C J Geiger; O M Palacios; M R Dicklin
Journal:  Eur J Clin Nutr       Date:  2016-09-28       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.